[1]
S. Pourmasumi, G. Hassanshahi, F. Esmaeili-ranjbar, N. Jalali, and M. Noroozi Karimabad, “Regulatory Effects of Various IFN-β Formulations Therapy on CXC Chemokines CXCL1 and CXCL9 Gene/Protein Levels in Relapsing-Remitting Multiple Sclerosis Patients: Regulatory effects of various IFN-β formulations therapy on CXC chemokines ”, Iran J Pharm Sci, vol. 20, no. 3, Sep. 2024.